Constellation Pharmaceuticals

About:

Constellation Pharmaceuticals develops drugs in the field of epigenetics focusing on selective regulators of its function.

Website: http://www.constellationpharma.com

Twitter/X: CPI_epigenetics

Top Investors: Hercules Capital, OrbiMed, Fidelity, Deerfield, Cormorant Asset Management

Description:

Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.

Total Funding Amount:

$721M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)constellationpharma.com

Founders:

Danny Reinberg, David Allis, Yang Shi

Number of Employees:

101-250

Last Funding Date:

2019-12-10

IPO Status:

Public

© 2025 bioDAO.ai